Chase Knickerbocker

Stock Analyst at Craig-Hallum

(4.76)
# 142
Out of 5,045 analysts
47
Total ratings
68.09%
Success rate
31.84%
Average return

Stocks Rated by Chase Knickerbocker

Harrow
Sep 23, 2025
Maintains: Buy
Price Target: $54$64
Current: $37.56
Upside: +70.39%
Indivior
Aug 27, 2025
Maintains: Buy
Price Target: $27$34
Current: $29.13
Upside: +16.72%
Fennec Pharmaceuticals
Aug 15, 2025
Maintains: Buy
Price Target: $13$14
Current: $8.33
Upside: +68.07%
PolyPid
Aug 14, 2025
Maintains: Buy
Price Target: $15$13
Current: $3.84
Upside: +238.54%
Xeris Biopharma Holdings
Aug 8, 2025
Maintains: Buy
Price Target: $6.5$11
Current: $9.71
Upside: +13.29%
DiaMedica Therapeutics
Jul 18, 2025
Maintains: Buy
Price Target: $8$11
Current: $7.00
Upside: +57.14%
Butterfly Network
Jul 1, 2025
Initiates: Buy
Price Target: $3
Current: $2.04
Upside: +47.06%
NeurAxis
Jun 16, 2025
Initiates: Buy
Price Target: $7
Current: $2.79
Upside: +150.90%
Phathom Pharmaceuticals
Jun 9, 2025
Maintains: Buy
Price Target: $12$17
Current: $13.31
Upside: +27.72%
Eton Pharmaceuticals
May 14, 2025
Maintains: Buy
Price Target: $26$28
Current: $18.25
Upside: +53.42%
Initiates: Buy
Price Target: $39
Current: $18.55
Upside: +110.24%
Maintains: Buy
Price Target: $10$8
Current: $1.50
Upside: +433.33%
Maintains: Buy
Price Target: $18$21
Current: $9.40
Upside: +123.40%
Maintains: Buy
Price Target: $5$6
Current: $3.90
Upside: +53.85%
Maintains: Buy
Price Target: $14$12
Current: $7.40
Upside: +62.16%
Initiates: Buy
Price Target: $10
Current: $6.12
Upside: +63.40%
Maintains: Buy
Price Target: $22$23
Current: $18.83
Upside: +22.15%
Maintains: Buy
Price Target: $1$1.2
Current: $0.92
Upside: +30.43%